US HB1781 | 2019-2020 | 116th Congress

Status

Spectrum: Slight Partisan Bill (Democrat 22-8)
Status: Engrossed on October 29 2019 - 50% progression, died in committee
Action: 2019-10-29 - Received in the Senate and Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Engrossed) [PDF]

Summary

Allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Payment Commission Data Act of 2019

Sponsors


History

DateChamberAction
2019-10-29SenateReceived in the Senate and Read twice and referred to the Committee on Finance.
2019-10-28HouseMotion to reconsider laid on the table Agreed to without objection.
2019-10-28HouseOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H8526)
2019-10-28HouseDEBATE - The House proceeded with forty minutes of debate on H.R. 1781.
2019-10-28HouseConsidered under suspension of the rules. (consideration: CR H8526-8527)
2019-10-28HouseMs. Schakowsky moved to suspend the rules and pass the bill, as amended.
2019-10-28HousePlaced on the Union Calendar, Calendar No. 205.
2019-10-28HouseCommittee on Ways and Means discharged.
2019-10-28HouseReported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-257, Part I.
2019-04-03HouseOrdered to be Reported (Amended) by Voice Vote.
2019-04-03HouseCommittee Consideration and Mark-up Session Held.
2019-03-27HouseForwarded by Subcommittee to Full Committee by Voice Vote .
2019-03-27HouseSubcommittee Consideration and Mark-up Session Held.
2019-03-15HouseReferred to the Subcommittee on Health.
2019-03-14HouseReferred to the Subcommittee on Health.
2019-03-14HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-03-14HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-03-14HouseIntroduced in House

Same As/Similar To

HB1264 (Same As) 2019-02-15 - Referred to the Subcommittee on Health.
SB801 (Related) 2019-03-14 - Read twice and referred to the Committee on Finance.
SB2543 (Related) 2019-09-25 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 225.
HB19 (Related) 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
SB3129 (Related) 2019-12-19 - Read twice and referred to the Committee on Finance.
SB4199 (Related) 2020-07-02 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4228)

Subjects


US Congress State Sources


Bill Comments

feedback